Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 25;9(3):190. doi: 10.3390/vaccines9030190

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Glycoprotein-enzyme-linked immunosorbent assay (GP-ELISA), plaque reduction neutralization test (PRNT), and seroresponse results by study for Partnership for Research on Ebola Virus in Liberia (PREVAIL), Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE), Guinea Front Line Worker (FLW) trial study, lot consistency study, and integrated results. (A): GP-ELISA GMTs (B): PRNT GMTs (C): GP-ELISA seroresponse ≥2-fold and ≥200 EU/mL rise from baseline (D): PRNT seroresponse ≥4-fold rise from baseline.